NEWS FROM THE JAW JOINTS & ALLIED MUSCULO-SKELETAL DISORDERS FOUNDATION and THE FORSYTH INSTITUTE

140 The Fenway · Boston, MA 02215· 617-266-2550 ·www.tmjoints.org.

 

Contact: Renée Glass, 617-266-2550 or TMJoints@aol.com

Contact: Jennifer Kelly, 617-892-8602 or jkelly@forsyth.org

 

 

FOR IMMEDIATE RELEASE                                                          December 14, 2005

 

Seminar Launches Post Doctoral Fellowship to Study Temporomandibular Muscle and Joint Disorders

 

Boston —On December 6, the effort to combat Temporomandibular Muscle and Joint Disorders (TMJD) took a large step forward. A seminar launching the Milton & Renée Glass Family Fellowship to study TMJD was held at The Forsyth Institute: the world’s leading independent organization dedicated to research and education in oral and craniofacial biology and related sciences. The goal of the

Fellowship is to understand the disease, prevent it, and identify effective therapies for its treatment.  It also provides a unique opportunity to promote awareness, prevention, and education related to TMJD in children.

 

Hosted by Dominick P. DePaola, D.D.S., Ph.D., President and CEO of Forsyth, the seminar began with an inspirational speech by the fellowship’s creators: Milton and Renée Glass, Co-Founders & Co-Presidents of the Jaw Joints & Allied Musculo-Skeletal Disorders Foundation. Mr. and Mrs. Glass provided an eye-opening account of how TMJD is often misdiagnosed and the people it affects are often misunderstood and disenfranchised. They emphasized the need to fund basic scientific research and discovery so that patients have better treatment in the short term — and in the long term, a cure. The Fellowship is intended to explore developmental aspects of the TMJ, with recognition of its diseases.

 

The opening lecture, “TMJ Research: From the Clinic to the Laboratory and Back Again” was given by Bjorn R. Olsen, M.D., Ph.D. Dr. Olsen is the Hersey Professor of Cell Biology at Harvard Medical School and the Dean for Research and Professor in the Department of Developmental Biology at Harvard School of Dental Medicine.

 

After giving a quick summary of current TMJD treatments and their shortcomings, Dr. Olsen offered up more promising looks into how the disease can be treated.  Dr. Olsen shared his extensive research of the Temporomandibular Joint’s characteristics (providing an understanding of how healthy TMJs work) and then delved into the symptoms and risk factors for TMJD patients. Using case studies and models, Dr. Olsen presented various potential causes of TMJD. He asserted that if certain underlying processes could be inhibited, so too could the disease. Noted Dr. Olsen, “We don’t have to necessarily wipe out TMJD.  We need only to slow it to the point where patients die from other natural causes before any impairment from TMJD might develop.  That would mean success.”

 

 

Following Dr. Olsen was Lawrence A. Tabak, D.D.S., Ph.D., the Director of National Institute of Dental and Craniofacial Research. His lecture was entitled: “The Role of NIH in Catalyzing Multi- and Interdisciplinary Research on Temporomandibular Muscle and Joint Diseases.”

 

Dr. Tabak began his speech declaring that when it comes to treating TMJD, people can make a difference. He underscored that people who advocate for TMJD research do so for the benefit of all patients. The key, he said, to successfully treating TMJD was an “Interdisciplinary Approach” involving a range of professionals such as: molecular biologists, mathematicians, sociologists, dentists, and physicians. Dr. Tabak also pointed out that it takes significant time and resources to assemble interdisciplinary teams. Said Dr. Tabak, “It’s going to take investigators who are brave…who are willing to do the unconventional…and take risks.” He called to action the young people in the audience in particular to take advantage of the little that is known about TMJD, and begin formulating new ways to discover what isn’t known or evident in the current literature.

 

Dr. Tabak spoke of NIH’s commitment to supporting new and innovative efforts to promote oral systemic health, and TMJD in particular. Under the auspices of NIDCR, collaboration has begun with the TMJD interagency working group, a large number of other NIH institutes, patient advocacy organizations and others. Said Dr. Tabak, “It’s a big job and one agency alone can’t do it. We need to work together to create a future where TMJ Disorders no longer exists.”

 

The seminar ended with Dr. DePaola from Forsyth Institute and Milton and Renée Glass presenting Dr. Olsen and Dr. Tabak with an award for their assistance in launching the post doctoral fellowship, on behalf of The Forsyth Institute and Jaw Joints & Allied Musculo-Skeletal Disorders Foundation.

 

***

 

The Forsyth Institute (www.forsyth.org) is the world’s leading independent organization dedicated to improving human health through innovative research and education in oral and craniofacial biology and related biomedical sciences. The Jaw Joints & Allied Musculo-Skeletal Disorders Foundation [www.tmjoints.org] is a 501[c][3] national educational, research, and advocacy organization. Founded in 1982, it promotes awareness, prevention, research and knowledge of the Jaw Joints to whole body health, and to Temporomandibular Joints Disorders [TMJD.]